Mary Ellen Wewers, PhD, MPH, professor of Health Behavior and Health Promotion, College of Public Health, and co-leader of the Cancer Control Program, has received a five-year, $2,974,000 grant from the NCI for a study titled Tobacco Cessation Interventions with Ohio Appalachian Smokers.
Amanda Ewart Toland, PhD, assistant professor of Molecular Virology, Immunology and Medical Genetics and a member of the Human Cancer Genetics Program, has received a three-year, $1,245,000 grant from the NCI for a study titled Genetic Interactions in Colorectal Cancer Susceptibility.
Gary Stoner, PhD, faculty emeritus of Hematology and Oncology, and professor of Pathology and of Human Nutrition, has received a four-year, $1,762,000 grant from the NCI for a study titled Prevention of Esophageal Cancer with Berries.
AWARDS AND HONORS
Michael Grever, MD, professor and chair of the Department of Internal Medicine and co-leader of the OSUCCC-James Experimental Therapeutics Program, has been elected to the Association of American Physicians, an organization closely allied with the American Society for Clinical Investigation. William Osler was a founding member of the organization, which today includes Nobel Laureates and members of the National Academy of Sciences and the Institute of Medicine.
The Division of Plastic Surgery has received two awards from the American Society of Reconstructive Microsurgery, one for “Best Case of the Year” and the other for “Best Save of the Year.” Michael Miller, MD, professor and division director, says the awards are particularly noteworthy because the University has never before participated in this competition, and no university has ever won both awards at the same meeting.
Susan Geyer, PhD, has joined the cancer program as an associate professor in the Division of Hematology and Oncology and as a senior biostatistical scientist in the Center for Biostatistics. Formerly, Geyer was an associate senior scientist at the National Academy of Sciences, working with the Radiation Effects Research Foundation in Hiroshima, Japan. Her research interests include evaluating high dimensional and potentially correlated data (e.g., complete immune function data and imaging data), longitudinal data analysis and clinical trial designs for targeted therapy.
The U.S. Food and Drug Administration has approved a phase I clinical trial for an agent designed and synthesized in the laboratory of OSUCCC-James researcher Ching-Shih Chen, PhD, professor of Medicinal Chemistry, of Internal Medicine and of Urology. The agent, AR-42 (OSU-HDAC42), is a histone deacetylase inhibitor that shows promise in leukemia, multiple myeloma, lymphoma and prostate cancer. Chen’s lab also designed and synthesized an earlier drug, AR-12 (OSU-0312), which in preclinical models inhibited solid tumors and lymphoma and is now in phase I testing.
Research from the lab of Maura Gillison, MD, PhD, medical oncologist and head and neck cancer specialist, has been highlighted for the third consecutive year by the American Society of Clinical Oncology (ASCO) in its annual report of important clinical advances.
Scott Jewell, PhD, associate director for biorepository and biospecimen resources at the OSUCCC-James, has been elected as president-elect of the International Society for Biological and Environmental Repositories (ISBER) for 2010-11.
Michael Lairmore, DVM, PhD, associate director for basic sciences at the OSUCCC-James, has been elected president of the American College of Veterinary Pathologists. The College fosters excellence in veterinary pathology to protect and improve animal, human and environmental health to benefit society.
Clay Marsh, MD, executive director of the Center for Personalized Health Care and director of the Center for Critical Care at The Ohio State University Medical Center, has been named to the Personalized Medicine Coalition’s (PMC) board of directors. The PMC is an educational and advocacy group comprising pharmaceutical, biotechnology, diagnostics and information technology companies, as well as major academic institutions and governmental agencies.
Carlo Croce, MD, who leads the Human Cancer Genetics Program at Ohio State, is included in the list of the world’s “12 Hottest Researchers” for 2009 compiled by Thomson Reuters Science Watch. Researchers on the list have published the most “hot papers” in the last two years as derived from Thomson Reuters’ Web of ScienceSM database. Croce was also named in the 2008 list.